Background: Following the availability of new drugs for chronic heart failure with reduced ejection fraction (HFrEF), we sought to provide an updated and comparative synthesis of the evidence on HFrEF pharmacotherapy efficacy. Methods: We performed a Bayesian network meta-analysis of phase 2 and 3 randomized controlled trials (RCTs) of medical...
-
2022 (v1)PublicationUploaded on: March 27, 2023
-
2021 (v1)Publication
Aims: We assessed the efficacy of the drugs developed after neurohormonal inhibitors (NEUi) in patients with heart failure with reduced ejection fraction (HFrEF) and concomitant chronic kidney disease (CKD). Methods and results: The literature was systematically searched for phase 3 randomized controlled trials (RCTs) involving ≥90% patients...
Uploaded on: April 14, 2023